Matches in Wikidata for { <http://www.wikidata.org/entity/Q91699722> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q91699722 description "artículu científicu espublizáu en mayu de 2017" @default.
- Q91699722 description "im Mai 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91699722 description "scientific article published on 24 May 2017" @default.
- Q91699722 description "wetenschappelijk artikel" @default.
- Q91699722 description "наукова стаття, опублікована в травні 2017" @default.
- Q91699722 name "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 name "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 type Item @default.
- Q91699722 label "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 label "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 prefLabel "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 prefLabel "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 P1433 Q91699722-833E90F3-8D59-419E-A29E-A0794F6AC6B2 @default.
- Q91699722 P1476 Q91699722-42468EB0-24E9-46E4-8698-06F2B92BA088 @default.
- Q91699722 P2093 Q91699722-32CF8EB6-16BA-4A41-AB1A-E8BC55A29823 @default.
- Q91699722 P2093 Q91699722-3471AED8-6C5D-4B99-81C2-A18BC6620AA4 @default.
- Q91699722 P2093 Q91699722-3E79CEA2-9BD0-4F65-A4E3-22F3F91C29B9 @default.
- Q91699722 P2093 Q91699722-7EFF456B-EA2B-4C68-9B90-0E10B5EE5050 @default.
- Q91699722 P2093 Q91699722-97D130CE-22A0-4609-A335-8F906C341E67 @default.
- Q91699722 P2093 Q91699722-B907CA46-6C00-4C52-878E-5B3ED2B5FF0F @default.
- Q91699722 P304 Q91699722-1895EBFA-115A-459C-AA1A-7C619A8D46F8 @default.
- Q91699722 P31 Q91699722-1BAE89EC-3C3D-4297-8B48-BC29D3C2E4A6 @default.
- Q91699722 P356 Q91699722-6FCD8F64-DA22-4EEF-8B72-782439D51684 @default.
- Q91699722 P433 Q91699722-FF463C28-D3B2-43EA-82A2-0BFB6FC6F2F4 @default.
- Q91699722 P478 Q91699722-30A6D9F3-DB00-46B1-9E8F-A647E9B8BCA5 @default.
- Q91699722 P577 Q91699722-A0351DD6-4FA6-40C0-91F6-BA6293BC8D33 @default.
- Q91699722 P698 Q91699722-712709C5-2FEC-47D0-9324-358C492286CA @default.
- Q91699722 P921 Q91699722-93637538-D067-434A-9196-04851B78872B @default.
- Q91699722 P356 C7TB00655A @default.
- Q91699722 P698 32264312 @default.
- Q91699722 P1433 Q18712374 @default.
- Q91699722 P1476 "Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance" @default.
- Q91699722 P2093 "Bo-Ya Liu" @default.
- Q91699722 P2093 "Jin-Long Wu" @default.
- Q91699722 P2093 "Meng-Qing Gong" @default.
- Q91699722 P2093 "Ren-Xi Zhuo" @default.
- Q91699722 P2093 "Si-Xue Cheng" @default.
- Q91699722 P2093 "Xiao-Yan He" @default.
- Q91699722 P304 "4697-4704" @default.
- Q91699722 P31 Q13442814 @default.
- Q91699722 P356 "10.1039/C7TB00655A" @default.
- Q91699722 P433 "24" @default.
- Q91699722 P478 "5" @default.
- Q91699722 P577 "2017-05-24T00:00:00Z" @default.
- Q91699722 P698 "32264312" @default.
- Q91699722 P921 Q1392806 @default.